Results 201 to 210 of about 42,053 (258)

Novel Drug Screening Assay for Acanthamoeba castellanii and the Anti-Amoebic Effect of Carbonic Anhydrase Inhibitors. [PDF]

J Med Chem
Haapanen S, Barker H, Carta F, Supuran CT, Parkkila S.   +4 more
europepmc   +1 more source

Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies. [PDF]

Pharmaceuticals (Basel)
Giampietro L, Marinacci B, Della Valle A, D'Agostino I, Lauro A, Mori M, Carradori S, Ammazzalorso A, De Filippis B, Maccallini C, Angeli A, Capasso C, Francati S, Mollica A, Grande R, Supuran CT.   +15 more
europepmc   +1 more source

The carbonic anhydrase inhibitor in serum

The Journal of Physiology, 1938
openaire   +3 more sources

Human Carbonic Anhydrase Inhibitors

ACS Medicinal Chemistry Letters
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Carborane‐Based Carbonic Anhydrase Inhibitors

Angewandte Chemie International Edition, 2013
CA inhibitors: Human carbonic anhydrases (CAs) are diagnostic and therapeutic targets. Various carborane cages are shown to act as active-site-directed inhibitors, and substitution with a sulfamide group and other substituents leads to compounds with high selectivity towards the cancer-specific isozyme IX.
Brynda, J. (Jiří), Mader, P. (Pavel), Šícha, V. (Václav), Fábry, M. (Milan), Poncová, K. (Kristýna), Bakardjiev, M. (Mario), Grüner, B. (Bohumír), Cígler, P. (Petr), Řezáčová, P. (Pavlína)   +8 more
openaire   +5 more sources

Novel Carbonic Anhydrase Inhibitors

Future Medicinal Chemistry, 2021
Abstract
openaire   +3 more sources

Carbonic Anhydrase Inhibitors

ChemInform, 2002
AbstractFor Abstract see ChemInform Abstract in Full Text.
SCOZZAFAVA, ANDREA, SUPURAN, CLAUDIU TRANDAFIR, A. CASINI   +2 more
openaire   +3 more sources

Antiobesity Carbonic Anhydrase Inhibitors

Current Topics in Medicinal Chemistry, 2007
Few pharmacological approaches for the treatment of obesity exist at this time, and most of them are unsatisfactory, whereas this disease is widespread both in the developed and developing world. Novel effective approaches are needed for the development of antiobesity agents possessing different mechanisms of action.
G. D. Simone, SUPURAN, CLAUDIU TRANDAFIR
openaire   +6 more sources

Topical carbonic anhydrase inhibitors

Current Opinion in Ophthalmology, 1997
Dorzolamide, a topically active carbonic anhydrase inhibitor, is an effective new glaucoma medication that creates a decrease in intraocular pressure similar to that produced by beta-blockers. When beta-blockers are contraindicated, dorzolamide may be used as a first-line therapy.
D M, Talluto, T B, Wyse, T, Krupin
openaire   +4 more sources